Winton Group’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-19,905
Closed -$2.27M 852
2025
Q1
$2.27M Sell
19,905
-3,770
-16% -$431K 0.14% 166
2024
Q4
$1.19M Buy
23,675
+4,520
+24% +$228K 0.08% 233
2024
Q3
$886K Sell
19,155
-16,684
-47% -$772K 0.06% 348
2024
Q2
$1.16M Sell
35,839
-4,433
-11% -$144K 0.08% 182
2024
Q1
$1.01M Buy
40,272
+24,775
+160% +$624K 0.07% 249
2023
Q4
$503K Buy
15,497
+22
+0.1% +$715 0.04% 314
2023
Q3
$422K Sell
15,475
-7,248
-32% -$197K 0.03% 328
2023
Q2
$506K Sell
22,723
-88,850
-80% -$1.98M 0.04% 311
2023
Q1
$2.42M Buy
111,573
+230
+0.2% +$4.98K 0.15% 168
2022
Q4
$2.26M Buy
111,343
+7,323
+7% +$149K 0.15% 176
2022
Q3
$2.67M Sell
104,020
-25,324
-20% -$649K 0.17% 139
2022
Q2
$3.08M Buy
129,344
+12,196
+10% +$290K 0.16% 158
2022
Q1
$2.64M Sell
117,148
-1,422
-1% -$32K 0.14% 177
2021
Q4
$2.35M Sell
118,570
-3,754
-3% -$74.3K 0.14% 177
2021
Q3
$2.41M Buy
122,324
+9,589
+9% +$189K 0.13% 128
2021
Q2
$2.48M Buy
112,735
+7,383
+7% +$162K 0.13% 112
2021
Q1
$2.51M Sell
105,352
-5,157
-5% -$123K 0.14% 83
2020
Q4
$2.89M Sell
110,509
-247,769
-69% -$6.48M 0.21% 44
2020
Q3
$6.24M Sell
358,278
-187,868
-34% -$3.27M 0.2% 74
2020
Q2
$9.19M Sell
546,146
-86,653
-14% -$1.46M 0.24% 51
2020
Q1
$7.52M Sell
632,799
-22,595
-3% -$269K 0.2% 124
2019
Q4
$7.93M Buy
655,394
+595,403
+992% +$7.2M 0.11% 312
2019
Q3
$848K Buy
59,991
+35,412
+144% +$501K 0.01% 907
2019
Q2
$274K Buy
+24,579
New +$274K 0.01% 928
2019
Q1
Sell
-12,545
Closed -$168K 1095
2018
Q4
$168K Sell
12,545
-7,193
-36% -$96.3K ﹤0.01% 826
2018
Q3
$277K Sell
19,738
-2,956
-13% -$41.5K 0.01% 845
2018
Q2
$357K Sell
22,694
-13,029
-36% -$205K 0.01% 762
2018
Q1
$588K Buy
+35,723
New +$588K 0.02% 696